Re: HDL from an Alzheimer's disease perspective
in response to
by
posted on
Jun 27, 2019 11:49AM
"For me, RVX208 was all about boosting the reverse cholesterol transport mechanism."
Yes, that was the old school model before it was discovered that RVX-208 was a bromodomain-2 selective BET inhibitor that elicits effects far beyond just apolipoprotein-AI and HDL-cholesterol modulation.
BDAZ